177 related articles for article (PubMed ID: 25062667)
1. Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma.
Lim S; Lee S; Lim JY; Park JS; Seong JS; Chang WS; Han KH; Choi HJ
J Neurooncol; 2014 Oct; 120(1):199-207. PubMed ID: 25062667
[TBL] [Abstract][Full Text] [Related]
2. Prognostic stratification of brain metastases from hepatocellular carcinoma.
Kim KS; Kim K; Chie EK; Kim YJ; Yoon JH; Lee HS; Ha SW
J Neurooncol; 2014 Oct; 120(1):209-14. PubMed ID: 25052350
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a Disease-Specific Graded Prognostic Assessment for Hepatocellular Carcinoma Patients with Spinal Metastasis.
Rim CH; Choi C; Choi J; Seong J
Gut Liver; 2017 Jul; 11(4):535-542. PubMed ID: 28506029
[TBL] [Abstract][Full Text] [Related]
4. [Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors in 31 cases].
Zhang RL; Zhang H; Zhang L; Xiao L; Sun YN; Yang Y; Bao YX
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):305-9. PubMed ID: 27087379
[TBL] [Abstract][Full Text] [Related]
5. Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors.
Jiang XB; Ke C; Zhang GH; Zhang XH; Sai K; Chen ZP; Mou YG
BMC Cancer; 2012 Feb; 12():49. PubMed ID: 22292912
[TBL] [Abstract][Full Text] [Related]
6. Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC.
Choi HJ; Cho BC; Sohn JH; Shin SJ; Kim SH; Kim JH; Yoo NC
J Neurooncol; 2009 Feb; 91(3):307-13. PubMed ID: 18949445
[TBL] [Abstract][Full Text] [Related]
7. Control of intracranial disease is associated with improved survival in patients with brain metastasis from hepatocellular carcinoma.
Nam HC; Sung PS; Song DS; Kwon JH; Nam SW; Yoon DJ; Jang JW; Choi JY; Yoon SK; Moon SW; Jang HS; Park JS; Jeun SS; Hong YK; Bae SH
Int J Clin Oncol; 2019 Jun; 24(6):666-676. PubMed ID: 30788672
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors.
Uchino K; Tateishi R; Shiina S; Kanda M; Masuzaki R; Kondo Y; Goto T; Omata M; Yoshida H; Koike K
Cancer; 2011 Oct; 117(19):4475-83. PubMed ID: 21437884
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.
Hu C; Yang J; Huang Z; Liu C; Lin Y; Tong Y; Fan Z; Chen B; Wang C; Zhao CL
BMC Cancer; 2020 Jun; 20(1):494. PubMed ID: 32487048
[TBL] [Abstract][Full Text] [Related]
10. Brain metastasis from hepatocellular carcinoma: the role of surgery as a prognostic factor.
Han MS; Moon KS; Lee KH; Cho SB; Lim SH; Jang WY; Jung TY; Kim IY; Jung S
BMC Cancer; 2013 Dec; 13():567. PubMed ID: 24289477
[TBL] [Abstract][Full Text] [Related]
11. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
13. Gamma Knife surgery for treating brain metastases arising from hepatocellular carcinomas.
Park ES; Kwon DH; Park JB; Lee DH; Cho YH; Kim JH; Kim CJ
J Neurosurg; 2014 Dec; 121 Suppl():102-9. PubMed ID: 25434943
[TBL] [Abstract][Full Text] [Related]
14. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
[TBL] [Abstract][Full Text] [Related]
15. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
Sperduto PW; Kased N; Roberge D; Xu Z; Shanley R; Luo X; Sneed PK; Chao ST; Weil RJ; Suh J; Bhatt A; Jensen AW; Brown PD; Shih HA; Kirkpatrick J; Gaspar LE; Fiveash JB; Chiang V; Knisely JP; Sperduto CM; Lin N; Mehta M
J Clin Oncol; 2012 Feb; 30(4):419-25. PubMed ID: 22203767
[TBL] [Abstract][Full Text] [Related]
16. Validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: extra-cranial disease progression is an independent risk factor.
Zhuang Q; Wong RX; Lian WX; Li YQ; Wong FY
Ann Palliat Med; 2019 Sep; 8(4):390-400. PubMed ID: 30943738
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective comparison with previously known prognostic models.
Baek KK; Kim JH; Uhm JE; Park SH; Lee J; Park JO; Park YS; Kang WK; Lim HY
Oncology; 2011; 80(3-4):167-74. PubMed ID: 21701230
[TBL] [Abstract][Full Text] [Related]
18. Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study.
Villà S; Weber DC; Moretones C; Mañes A; Combescure C; Jové J; Puyalto P; Cuadras P; Bruna J; Verger E; Balañà C; Graus F
Radiat Oncol; 2011 Mar; 6():23. PubMed ID: 21366924
[TBL] [Abstract][Full Text] [Related]
19. Nomogram prediction of survival in patients with brain metastases from hepatocellular carcinoma treated with whole-brain radiotherapy: a multicenter retrospective study.
Park Y; Kim KS; Kim K; Chie EK; Kim JH; Kim JS; Kim TH; Kim DY; Jang WI; Kim MS; Koo TR; Chang AR
J Neurooncol; 2015 Nov; 125(2):377-83. PubMed ID: 26342711
[TBL] [Abstract][Full Text] [Related]
20. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
